Quoin Pharmaceuticals: QRX003 compassionate use case report accepted for publication

Quoin Pharmaceuticals announced acceptance of a peer-reviewed paper on QRX003 for Netherton syndrome in Dermatology and Therapy. Results described fully healed skin and elimination of itch in a pediatric compassionate-use case report.